PATHOGENESIS OF HYPERTENSION
高血压的发病机制
基本信息
- 批准号:3485243
- 负责人:
- 金额:$ 24.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1974
- 资助国家:美国
- 起止时间:1974-09-01 至 1997-08-31
- 项目状态:已结题
- 来源:
- 关键词:adenoma adrenal ferredoxin adrenal glands adrenocorticotropic hormone aldosterone androgens complementary DNA cyclic AMP electron microscopy fluorimetry gene expression glucocorticoids hormone regulation /control mechanism human tissue melanocyte stimulating hormone messenger RNA nucleic acid sequence oxygenases pituitary adrenal axis proopiomelanocortin protein biosynthesis radioimmunoassay spontaneous hypertensive rat steroid 11beta monooxygenase steroid biosynthesis
项目摘要
The proposed studies are designed to evaluate the hypothesis that
adrenocortical dysfunction related to altered synthesis or control
of key steroidogenic enzymes can lead to increased secretion of
hypertensinogenic steroids from the adrenal. The major focus
initially will be on the pathogenesis of androgen-induced
hypertension where our previous studies have revealed that there
are selective effects of androgens on cytochrome P-450-11 beta
activity of the adrenocortical inner zones. The mechanism of this
will be studied by measuring steroidogenic enzyme gene
expression from control and androgen-treated rats. Specific
antibodies will be used to quantitate cytochrome P-450-11 beta as
well as P-450scc, adrenodoxin, P-450-21 and NADPH-cytochrome
P-450 reductase using immunoisolation techniques. cDNA's
against P-450-11 beta, P-450scc and P-450-21 will be used to
quantitate mRNA's encoding for these enzymes. In view of
potential effects of androgen on the secretion of
proopiomelanocortin (POMC)-derived peptides, these studies will
be extended to adrenocortical cells in primary culture. Also, we
will measure the effect of androgens on circulating and pituitary
levels of POMC-derived peptides as well as direct effects of
androgens on pituitary cell cultures. In related studies we
examine the gene expression of key adrenal steroidogenic
enzymes in regenerating adrenals in order to understand more
fully how altered levels of these enzymes is related to increased
biosynthesis of mineralocorticoids. Spontaneously hypertensive
rats (SHR) will also be studied in the prehypertensive and
hypertensive state in order to identify potential abnormalities in
adrenal and pituitary hormone biosynthesis. Our work with
POMC-derived peptides will emphasize pro-gamma-MSH's shown
by us to synergize with ACTH in stimulating aldosterone and
glucocorticoid secretion. We will study the mechanism of action
of pro-gamma-MSH's in normal rat adrenal zona glomerulosa
tissue and also in human aldosteronoma cells. These studies have
the potential for enhancing our understanding of the altered
control of aldosterone production in aldosterone-secreting
adenomas as well as the role in normal glomerulosa and
aldosteronoma cells of a hormone- and cAMP-responsive
steroidogenesis activator polypeptide (SAP), recently isolated and
characterized by us.
拟议的研究旨在评估以下假设:
与合成或控制改变有关的肾上腺皮质功能障碍
关键的类固醇生成酶可以导致分泌增加
来自肾上腺的致高血压类固醇。 主要焦点
首先将探讨雄激素诱发的发病机制
我们之前的研究表明,高血压
是雄激素对细胞色素 P-450-11 beta 的选择性作用
肾上腺皮质内部区域的活动。 这个的机制
将通过测量类固醇生成酶基因来研究
对照和雄激素处理的大鼠的表达。 具体的
抗体将用于定量细胞色素 P-450-11 beta
以及 P-450scc、肾上腺素、P-450-21 和 NADPH-细胞色素
使用免疫分离技术的 P-450 还原酶。 cDNA的
针对 P-450-11 beta,P-450scc 和 P-450-21 将用于
定量这些酶的 mRNA 编码。 鉴于
雄激素对分泌的潜在影响
阿黑皮素原 (POMC) 衍生的肽,这些研究将
扩展到原代培养物中的肾上腺皮质细胞。 另外,我们
将测量雄激素对循环和垂体的影响
POMC 衍生肽的水平以及直接影响
垂体细胞培养物中的雄激素。 在相关研究中我们
检查关键肾上腺类固醇生成的基因表达
肾上腺再生酶,以便了解更多
充分了解这些酶的水平改变与增加
盐皮质激素的生物合成。 自发性高血压
大鼠(SHR)也将在高血压前期和
高血压状态,以识别潜在的异常
肾上腺和垂体激素的生物合成。 我们的工作与
POMC 衍生肽将强调 pro-gamma-MSH
我们与 ACTH 协同刺激醛固酮,
糖皮质激素的分泌。 我们将研究作用机制
正常大鼠肾上腺球状带中前-gamma-MSH的变化
组织以及人醛固酮瘤细胞中。 这些研究有
增强我们对改变的理解的潜力
醛固酮分泌中醛固酮产生的控制
腺瘤以及在正常肾小球和中的作用
激素和 cAMP 响应的醛固酮瘤细胞
类固醇生成激活剂多肽(SAP),最近分离和
以我们为特色。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER C BROWNIE其他文献
ALEXANDER C BROWNIE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER C BROWNIE', 18)}}的其他基金
ADRENOCORTICAL HORMONES IN OBESITY-RELATED HYPERTENSION
肥胖相关高血压中的肾上腺皮质激素
- 批准号:
3356204 - 财政年份:1987
- 资助金额:
$ 24.41万 - 项目类别:
ADRENOCORTICAL HORMONES IN OBESITY-RELATED HYPERTENSION
肥胖相关高血压中的肾上腺皮质激素
- 批准号:
3356203 - 财政年份:1987
- 资助金额:
$ 24.41万 - 项目类别:
ADRENOCORTICAL HORMONES IN OBESITY-RELATED HYPERTENSION
肥胖相关高血压中的肾上腺皮质激素
- 批准号:
3356205 - 财政年份:1987
- 资助金额:
$ 24.41万 - 项目类别:
ADRENOCORTICAL HORMONES IN OBESITY-RELATED HYPERTENSION
肥胖相关高血压中的肾上腺皮质激素
- 批准号:
3356202 - 财政年份:1987
- 资助金额:
$ 24.41万 - 项目类别:
ADRENOCORTICAL HORMONES IN OBESITY-RELATED HYPERTENSION
肥胖相关高血压中的肾上腺皮质激素
- 批准号:
3356201 - 财政年份:1987
- 资助金额:
$ 24.41万 - 项目类别:
CONTROL OF STEROIDOGENESIS IN ADRENAL CORTICAL TISSUE
肾上腺皮质组织中类固醇生成的控制
- 批准号:
3225952 - 财政年份:1978
- 资助金额:
$ 24.41万 - 项目类别:
CONTROL OF STEROIDOGENESIS IN ADRENAL CORTICAL TISSUE
肾上腺皮质组织中类固醇生成的控制
- 批准号:
3151121 - 财政年份:1978
- 资助金额:
$ 24.41万 - 项目类别: